Getting Closer to the Real Bacterial Cell Wall Target: Biomolecular Interactions of Water‐Soluble Lipid II with Glycopeptide Antibiotics
- 20 March 2003
- journal article
- Published by Wiley in Chemistry – A European Journal
- Vol. 9 (7) , 1556-1565
- https://doi.org/10.1002/chem.200390179
Abstract
A novel synthesized water‐soluble variant of lipid II (LII) was used to evaluate the noncovalent interactions between a number of glycopeptide antibiotics and their receptor by bioaffinity electrospray ionization mass spectrometry (ESI‐MS). The water‐soluble variant of lipid II is an improved design, compared to the traditionally used tripeptide N,N′‐diacetyl‐L‐lysyl‐D‐alanyl‐D‐alanine (KAA), of the target molecule on the bacterial cell wall. A representative group of glycopeptide antibiotics was selected for this study to evaluate the validity of the novel cell‐wall‐mimicking target LII. Structure–function relationships of various glycopeptide antibiotics were investigated by means of 1) bioaffinity mass spectrometry to evaluate solution‐phase molecular interactions with both LII and KAA, 2) fluorescence leakage experiments to study the interactions with the membrane‐embedded lipid II, and 3) minimum inhibitory concentrations against the indicator strain Micrococcus flavus. Our results with the novel LII molecule reveal that some antibiotics interact differently with KAA and LII. Additionally, our data cast doubt on the hypothesis that antibiotic selfdimerization assists in the in‐vivo efficacy. Finally, the water‐soluble lipid II proved to be a better model of the bacterial cell wall.Keywords
This publication has 46 references indexed in Scilit:
- The Role of Sugar Residues in Molecular Recognition by VancomycinJournal of Medicinal Chemistry, 2001
- Interactions of α- and β-avoparcin with bacterial cell-wall receptor-mimicking peptides studied by electrospray ionization mass spectrometryJournal of Antimicrobial Chemotherapy, 1999
- Subtle differences in molecular recognition between modified glycopeptide antibiotics and bacterial receptor peptides identified by electrospray ionization mass spectrometryJournal of the Chemical Society, Perkin Transactions 2, 1999
- Thermal Atropisomerism of Aglucovancomycin Derivatives: Preparation of (M,M,M)- and (P,M,M)-AglucovancomycinsJournal of the American Chemical Society, 1998
- Binding of D-serine-terminating cell-wall analogues to glycopeptide antibioticsChemical Communications, 1998
- Asymmetry in the structure of glycopeptide antibiotic dimers: NMR studies of the ristocetin A complex with a bacterial cell wall analogJournal of the American Chemical Society, 1995
- Ligands which bind weakly to vancomycin: studies by 13C NMR spectroscopyJournal of the Chemical Society, Perkin Transactions 2, 1995
- The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibioticsStructure, 1994
- Detailed binding sites of the antibiotics vancomycin and ristocetin A: determination of intermolecular distances in antibiotic/substrate complexes by use of the time-dependent NOEJournal of the American Chemical Society, 1983
- Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycinBiochemical and Biophysical Research Communications, 1966